Tyrosine supplementation in phenylketonuria: Diurnal blood tyrosine levels and presumptive brain influx of tyrosine and other large neutral amino acids

Journal of Pediatrics

Volumn 139, Issue 3, 2001, Pages 421-427

  Kalsner, Louisa R ^a   Rohr, Frances J ^a   Strauss, Kevin A ^a   Korson, Mark S ^a   Levy, Harvey L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TYROSINE;

AMINO ACID BLOOD LEVEL; AMINO ACID TRANSPORT; ARTICLE; BLOOD BRAIN BARRIER; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DIET SUPPLEMENTATION; FEMALE; HUMAN; MALE; PHENYLKETONURIA; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0034820109     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2001.117576     Document Type: Article

References (47)

1. The hyperphenylalaninemias
2. Admissions of phenylketonuric patients to residential institutions before and after screening programs of the newborn infant
3. Intellectual performance of 36 phenylketonuria patients and their nonaffected siblings
4. Neuropsychology of early-treated phenylketonuria: Specific executive function deficits
5. Neurological outcome in adult patients with early-treated phenylketonuria
6. Executive function in school-aged children with phenylketonuria
7. Executive function impairment and neurotransmitter deficiency in early-treated phenylketonuria (PKU) patients under dietary treatment
8. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU
9. D1 dopamine receptors in prefrontal cortex: Involvement in working memory
10. Mesocortical dopamine neurons: Rapid transmitter turnover compared to other brain catecholamine systems
11. Mesocortical dopamine neurons: High basal firing frequency predicts tyrosine dependence of dopamine synthesis
12. Phenylalanine transport at the human blood brain barrier
13. Kinetics of neutral amino acid transport across the blood-brain barrier
14. National Institutes of Health Consensus Development Conference. Phenylketonuria: Screening and management
15. Fasting plasma amino acid concentrations in PKU children on two different levels of protein intake
16. Low serum-tyrosine in patients with phenylketonuria on dietary treatment
17. Hypotyrosinemia in phenylketonuria
18. Tyrosine supplementation in the treatment of maternal phenylketonuria
19. New England Maternal PKU project: Prospective study of untreated and treated pregnancies and their outcomes
20. The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain
21. Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatment
22. Unsuccessful treatment of phenylketonuria with tyrosine
23. Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria
24. Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine
25. Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria
26. Cognition and tyrosine supplementation among school-aged children with phenylketonuria
27. Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria
28. Tyrosine requirement in children with classical PKU determined by indicator amino acid oxidation
29. Quantitative metabolic profiling of urinary organic acids by gas chromatographymass spectrometry: Comparison of isolation methods
30. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry
31. Kinetic analysis of neutral amino acid transport across the blood-brain barrier
32. Regulation of cerebral metabolism of amino acids-IV
33. The influence of high phenylalanine and tyrosine on the concentrations of essential amino acids in brain
34. Daily rhythms in the concentrations of various amino acids in human plasma
35. Inverse diurnal variations of serum phenylalanine and tyrosine in phenylketonuric children on low-phenylalanine diet
36. Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria
37. Behavioural and emotional problems in early-treated adolescents with phenylketonuria in comparison with diabetic patients and healthy-controls
38. Phenylalanine transport at the human blood-brain barrier. Studies with isolated human brain capillaries
39. Neutral amino acid transport at the human blood-brain barrier
40. 11C-methionine in phenylketonuria
41. Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo
42. Large neutral amino acids block phenylalanine transport in brain tissue in patients with phenylketonuria
43. Hyperaminoacidemia effects on intestinal transport of related amino acids
44. Case studies of the effect of tyrosine administration in children with phenylketonuria on cognitive processes
45. Necessity of complete intake of phenylalanine-free amino acid mixture for metabolic control of phenylketonuria
46. On the enzymic defects in hereditary tyrosinemia